Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Steve Jeremiah"'
Autor:
Mykola Tronko, G.A. Thomas, J.A. Bethel, Ned Powell, T Bogdanova, J. Grubb, Steve Jeremiah, L.A. Stephens, E P Demidchik
Publikováno v:
Thyroid. 15:100-104
In both medullary carcinoma and papillary carcinoma of the thyroid, altered expression of the RET gene is implicated in tumorigenesis. Recent studies suggest that loss of heterozygosity (LOH) at the G691S SNP may be associated with tumors from patien
Autor:
T Bogdanova, Steve Jeremiah, Jackie Bethel, Mykola Tronko, Gerry Thomas, Edward G. Dudley, Ned Powell, Mariko Morishita
Publikováno v:
The Journal of Pathology. 205:558-564
In this study, the frequency of BRAF mutation was investigated in a series of 67 cases of papillary thyroid cancer (PTC) in patients from Ukraine. Thirty-two patients were aged 30 years or older at the time of diagnosis and 35 were under 16. Tumour w
Publikováno v:
Experimental Cell Research. 213:295-304
Fusion of hepatoma cells with cells of similar ploidy (1s) from different histogenetic origin results in the systematic and stable extinction of hepatic traits. However, doubling the ploidy of the hepatoma parent (2s) leads to the formation of hybrid
Publikováno v:
Microvascular research. 78(3)
Background Angiogenesis plays an essential role in the growth and metastatic development of tumours. Recent in vitro studies have reported bisphosphonates as having anti-angiogenic properties. They have been shown to inhibit proliferation, induce apo
Autor:
Manuel Sobrinho-Simões, Mykola Tronko, Tatyana I. Bogdanova, Gerry Thomas, Paula Soares, Massimo Santoro, Valdemar Máximo, Dillwyn Williams, J.F Magalhaes, Steve Jeremiah, Jorge Lima, Giuliana Salvatore, Vítor Trovisco, Alexander Abrosimov
Publikováno v:
89 (2004): 4267–4271.
info:cnr-pdr/source/autori:Lima J, Trovisco V, Soares P, Máximo V, Magalhães J, Salvatore G, Santoro M, Bogdanova T, Tronko M, Abrosimov A, Jeremiah S, Thomas G, Williams D, Sobrinho-Simões M./titolo:BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas./doi:/rivista:/anno:2004/pagina_da:4267/pagina_a:4271/intervallo_pagine:4267–4271/volume:89
info:cnr-pdr/source/autori:Lima J, Trovisco V, Soares P, Máximo V, Magalhães J, Salvatore G, Santoro M, Bogdanova T, Tronko M, Abrosimov A, Jeremiah S, Thomas G, Williams D, Sobrinho-Simões M./titolo:BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas./doi:/rivista:/anno:2004/pagina_da:4267/pagina_a:4271/intervallo_pagine:4267–4271/volume:89
The BRAF gene has been shown to be a major target for mutations in papillary thyroid carcinoma (PTC) (36-69%), which forms almost all of the over 2000 cases of thyroid carcinoma that have occurred in Chernobyl. BRAF is activated by point mutation, an
Autor:
Jorge Lima, Vítor Trovisco, Paula Soares, Valdemar Máximo, João Magalhães, Giuliana Salvatore, Massimo Santoro, Tatyana Bogdanova, Mykola Tronko, Alexander Abrosimov, Steve Jeremiah, Gerry Thomas, Dillwyn Williams, Manuel Sobrinho-Simões
Publikováno v:
Cancer Letters. 230:149-150
Publikováno v:
Microvascular Research. 78:141-141